Security key
21833P301
Corbus Pharmaceuticals Holdings, Inc. - Common Stock (CRBP)
CUSIP: 21833P301
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 12,828,485
- Total 13F value
- $120,454,148
- Share change
- -103,498
- Put/Call ratio
- 7.7%
- SEC-reported price per share
- $9.39
- Number of holders
- 107
- Value change
- +$569,311
- Number of buys
- 52
- Number of sells
- 34
- Shares outstanding
- 18,532,780
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
107
Top holders
10
CRBP full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Corbus Pharmaceuticals Holdings, Inc. SEC filings
Corbus Pharmaceuticals Holdings, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 21833P301
Recent filing periods:
Ownership snapshot
Top reported holders of CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Cormorant Asset Managemen...
Disclosed value leader
Cormorant Asset Managemen...
Comparable rows
15/15
Latest evidence
31 Dec 2025
3/4/5
13D/G
13F
Lead comparable stake: 13%
13D/G row: Cormorant Asset Management, LP
Showing 1-6 of 15 holder rows.
Quick read
Cormorant Asset Management, LP leads the comparable SEC ownership view at 13%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Cormorant Asset Management, LP's linked filing trail.
Comparable ownership
Top 5
Cormorant Asset Management, LP
13%
Aberdeen Group plc
7.5%
ORBIMED ADVISORS LLC
5.9%
CITADEL ADVISORS LLC
5.3%
VANGUARD GROUP INC
4.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Cormorant Asset Management, LP |
3/4/5
13D/G
13F
10%+ Owner · Company
|
13%
from 13D/G
|
$26,863,987
2,344,971 shares
|
-$344,012 | 11 Dec 2025 |
| Aberdeen Group plc |
13D/G
13F
Company
|
7.5%
|
$10,759,045
1,321,750 shares
|
$0 | 31 Dec 2025 |
| ORBIMED ADVISORS LLC |
13F
13D/G
Company · OrbiMed Capital LLC
|
5.9%
from 13D/G
|
$13,001,916
1,597,287 shares
|
— | 31 Dec 2025 |
| CITADEL ADVISORS LLC |
13D/G
13F
Kenneth Griffin · Company
|
5.3%
|
$12,405,011
980,610 shares
|
$0 | 04 Nov 2025 |
| VANGUARD GROUP INC |
13F
13D/G
Company · The Vanguard Group
|
4.9%
from 13D/G
|
$6,995,573
859,407 shares
|
— | 31 Dec 2025 |
| Octagon Capital Advisors LP |
13F
Company
|
5.2%
|
$7,773,700
955,000 shares
|
— | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
107
Shares
12,828,485
Rows available
107
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q1 2026 Across Filers
Q1 2026 holders
107
Q1 2026 holders
107
Holder diff
0
| Investor | Q1 2026 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend